KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 120 filers reported holding KEROS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,311,480 | -11.1% | 378,807 | +28.8% | 1.02% | -8.5% |
| Q1 2024 | $19,462,601 | -23.9% | 293,997 | -54.3% | 1.11% | +45.4% |
| Q4 2023 | $25,568,940 | +135.1% | 643,082 | +88.5% | 0.76% | -17.6% |
| Q3 2023 | $10,873,662 | -46.9% | 341,081 | -33.1% | 0.93% | -53.1% |
| Q2 2023 | $20,470,143 | -36.5% | 509,461 | -32.5% | 1.98% | -19.8% |
| Q1 2023 | $32,243,581 | -19.5% | 755,119 | -9.5% | 2.47% | -4.8% |
| Q4 2022 | $40,048,344 | +19.9% | 833,993 | -6.0% | 2.60% | +20.1% |
| Q3 2022 | $33,391,000 | +26.7% | 887,592 | -6.9% | 2.16% | +63.6% |
| Q2 2022 | $26,354,000 | -43.6% | 953,801 | +11.1% | 1.32% | -36.1% |
| Q1 2022 | $46,698,000 | -4.6% | 858,730 | +2.7% | 2.07% | +20.0% |
| Q4 2021 | $48,938,000 | +62.7% | 836,398 | +10.0% | 1.72% | +81.6% |
| Q3 2021 | $30,081,000 | +18.3% | 760,383 | +27.0% | 0.95% | +31.1% |
| Q2 2021 | $25,434,000 | -10.2% | 598,880 | +30.1% | 0.72% | -12.7% |
| Q1 2021 | $28,336,000 | -24.8% | 460,372 | -13.9% | 0.83% | -29.1% |
| Q4 2020 | $37,705,000 | +253.1% | 534,514 | +93.1% | 1.17% | +257.2% |
| Q3 2020 | $10,677,000 | +3.5% | 276,827 | +0.7% | 0.33% | +5.1% |
| Q2 2020 | $10,315,000 | – | 275,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |